FOX BIZ NEWS: Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson

Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson



The case, which is premised on a unproven legal theory, could impact the course of future opioid litigation.

via FOX BUSINESS NEWS https://fxn.ws/2WUGlae